ValuentumAd

Official PayPal Seal
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Apr 16, 2019
Disney Pushes Deeper into the Streaming Market While Cooling Off on Future Star Wars Movie Releases
Entertainment giant Disney has been milking the Star Wars franchise for all its worth since acquiring Lucasfilms back in 2012. Now fans are starting to shun the franchise’s blockbuster movie releases and that has management considering how to properly leverage this top tier asset going forward.
Feb 5, 2019
Alphabet Working to Balance Rising Spending and Driving Revenue Growth
Alphabet’s top-line growth remains impressive, but rising costs continue to pressure margin performance. Free cash flow generation is still robust, which provides the backbone for its fortress-like balance sheet, but capital spending levels advanced at a significant rate in 2018.
Dec 19, 2018
Oracle Raises Internal Guidance; Share Buybacks Abound
Image Source: May Wong. Oracle’s fiscal 2019 second quarter report revealed expectations for accelerating top-line growth thanks in large part to strong momentum in bookings. The company’s technology leadership may be greater than ever before, and it continues to generate robust free cash flow. Management’s appetite for buybacks appears insatiable.
Nov 28, 2018
Cardinal Health Battling Bottom-Line Headwinds
Image Source: Global Panorama. Healthcare product distributor and Dividend Aristocrat Cardinal Health has had its share price performance in 2018 dampened by a number of factors, including generic drug price deflation weighing on its ‘Pharmaceutical’ segment, struggles in its ‘Medical’ segment, and the potential for disruption within its industry.
Nov 9, 2018
Alphabet’s Operating Margin Shrinks in Third Quarter; Free Cash Flow Still Robust
The company formerly known as Google continues to invest for long-term growth, which is impacting its operating margin and free cash flow, but the two measures remain solid, particularly the latter of the two. The company retains a level of financial flexibility that is matched by few other firms. 
Nov 9, 2018
Dividend Increases/Decreases for the Week Ending November 9
Let's take a look at companies that raised/lowered their dividend this week.
Jun 28, 2018
Amazon: The Destroyer of Other Companies’ Profits
Image Source: Victor. Amazon is stepping into the pharmacy business with the purchase of online pharmacy start-up PillPack. The market is implying the move will prove to be more than just a headache for those operating in the drug store/pharmacy and drug-distributor complex. Whether the impact will be significantly material in the coming years remains to be seen, but it’s a big directional negative for impacted parties.
Jun 20, 2018
Oracle’s Dividend Still Very Healthy
Image Source: May Wong. Oracle issued what is likely conservative fiscal first-quarter 2019 guidance, but the company continues to generate record amounts of operating cash flow and has a solid net cash position on the books. We’re not worried about the dividend.
May 15, 2018
Disney’s Top Line Growing as It Leverages Film Successes
Image Source: David Holt. Media giant Disney has been executing well of late as it leverages its successful content into a broader scope of entertainment, but competition may be heating up related to its pending acquisition of Twenty-First Century Fox’s media assets.
May 10, 2018
Generic Drug Deflation Continues to Hamper Cardinal Health and AmerisourceBergen
Image Source: Aaron Fulkerson. A severe case of rampant generic drug deflation continues to hamper the share prices of Cardinal Health and AmerisourceBergen. We are monitoring the drug deflation numbers posted by the drug wholesalers as a key gauge of the investment merits of the group.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.